This inventor holds 93 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Quinolone Derivatives (CPC class 546156). Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 1976-2011.
Inventors with similar research interests:
Location History:
- Cologne, DE (1976)
- Bayerwerk, DE (1991)
- Leverkusen, DE (1980 - 2011)
Company Filing History:
92 out of 12,266 
1 out of 386 
Years Active: 1976-2011
Areas of Expertise:
Title: Uwe Petersen: Pioneering Innovations in Pharmaceutical Patents
Introduction
Uwe Petersen, based in Leverkusen, Germany, has made significant contributions to the pharmaceutical industry with an impressive portfolio of 93 patents. His innovative work primarily focuses on treatments for bacterial diseases, showcasing a dedication to addressing critical health issues.
Latest Patents
Among his latest patents, Petersen has developed inhalable quinolonecarboxylic acid derivative compositions aimed at local control of respiratory organ diseases, particularly targeting lung conditions. Another notable invention involves the use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the associated gastroduodenal diseases. These patents reflect his commitment to advancing medical treatments through innovative pharmaceutical formulations.
Career Highlights
Uwe Petersen has built a robust career in the pharmaceutical sector, having worked with Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His tenure in these prestigious companies has allowed him to play a key role in developing cutting-edge treatments and pioneering research in the field of medicine.
Collaborations
Throughout his career, Petersen has collaborated with other esteemed professionals, including Karl G. Metzger and Klaus Grohe. These collaborations have contributed to the successful development of various pharmaceutical innovations, further enhancing his contributions to the industry.
Conclusion
Uwe Petersen's extensive patent portfolio and his collaborative efforts in the pharmaceutical sector underscore his status as a leading inventor. His inventions not only push the boundaries of medical science but also provide significant benefits in treating complex diseases, making a lasting impact on healthcare.